Dashboard
Manage Tickers

CTMX CytomX Therapeutics, Inc.

Nasdaq cytomx.com


$ 3.69 $ -0.57 (-13.6 %)    

Friday, 07-Nov-2025 17:34:25 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 3.62
$ 3.80
$ 3.56 x 100
$ 3.69 x 800
$ 3.35 - $ 3.88
$ 0.40 - $ 4.62
7,773,576
na
613.36M
$ 1.57
$ 21.89
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-06-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-11-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-27-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-24-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-27-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-07-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-05-2017 03-31-2017 10-Q
36 03-02-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-06-2016 03-31-2016 10-Q
40 03-07-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cytomx-therapeutics-q3-eps-009-misses-005-estimate-sales-5963m-miss-11625m-estimate
CytomX Therapeutics Q3 EPS $(0.09) Misses ...
11/06/2025 21:27:05

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

cytomx-therapeutics-to-present-initial-translational-data-from-ongoing-phase-1-study-of-cx-801-in-patients-with-advanced-melanoma-at-sitc-annual-meeting
CytomX Therapeutics To Present Initial Tra...
11/04/2025 14:16:41

- CX-801 (PROBODY® interferon alpha-2b) Phase 1 data demonstrate activation of tumor-selective interferon signaling in patients...

cytomx-therapeutics-stock-a-deep-dive-into-analyst-perspectives-4-ratings
CytomX Therapeutics Stock: A Deep Dive Int...
10/21/2025 21:01:50

barclays-maintains-overweight-on-cytomx-therapeutics-raises-price-target-to-6
Barclays Maintains Overweight on CytomX Th...
10/21/2025 11:50:23

Barclays analyst Etzer Darout maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and raises the price target from...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 21:06:11

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

cantor-fitzgerald-initiates-coverage-on-cytomx-therapeutics-with-overweight-rating-announces-price-target-of-6
Cantor Fitzgerald Initiates Coverage On Cy...
09/22/2025 12:26:40

Cantor Fitzgerald analyst Olivia Brayer initiates coverage on CytomX Therapeutics (NASDAQ:CTMX) with a Overweight rating and...

why-serina-therapeutics-shares-are-trading-higher-by-over-25-here-are-20-stocks-moving-premarket
Why Serina Therapeutics Shares Are Trading...
08/26/2025 09:52:07

intuit-workday-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Intuit, Workday And Other Big Stocks Movin...
08/22/2025 08:35:11

cytomx-therapeutics-provides-update-cx-2025-phase-1-study-in-response-to-social-media-posts
CytomX Therapeutics Provides Update Cx-202...
08/13/2025 12:07:40

- The CTMX-2051-101 study has enrolled 73 colorectal cancer patients to-date, aligned with the Company's goal of providing ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

cytomx-therapeutics-focused-on-cx-2051-clinical-date-update-in-q1-2026-and-potential-launch-of-phase-2-study-in-h1-2026
CytomX Therapeutics Focused On CX-2051 Cli...
08/07/2025 21:33:32

cytomx-therapeutics-files-for-mixed-shelf-of-up-to-250m
Cytomx Therapeutics Files For Mixed Shelf ...
08/07/2025 21:26:11

-SECFiling

cytomx-therapeutics-q2-sales-18658m-beat-14725m-estimate
CytomX Therapeutics Q2 Sales $18.658M Beat...
08/07/2025 20:13:53

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly sales of $18.658 million which beat the analyst consensus estimate of $14....

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

this-lexeo-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-thursday
This Lexeo Therapeutics Analyst Begins Cov...
07/31/2025 16:11:53

deep-dive-into-cytomx-therapeutics-stock-analyst-perspectives-4-ratings
Deep Dive Into CytomX Therapeutics Stock: ...
07/31/2025 13:01:12

oppenheimer-initiates-coverage-on-cytomx-therapeutics-with-outperform-rating-announces-price-target-of-7
Oppenheimer Initiates Coverage On CytomX T...
07/31/2025 12:04:50

Oppenheimer analyst Matthew Biegler initiates coverage on CytomX Therapeutics (NASDAQ:CTMX) with a Outperform rating and ann...

heico-monro-abercrombie--fitch-joby-aviation-and-other-big-stocks-moving-higher-on-wednesday
Heico, Monro, Abercrombie & Fitch, Joby Av...
05/28/2025 14:23:37

cytomx-therapeutics-stock-a-deep-dive-into-analyst-perspectives-4-ratings
CytomX Therapeutics Stock: A Deep Dive Int...
05/20/2025 12:01:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION